Programme and venue

Advances and Future of High-Grade Serous Ovarian Cancer Research

Time: Wednesday May 8, 2019
Place: Lecture hall 2, Biomedicum Helsinki 1, Haartmaninkatu 8, 00290 Helsinki

Link to the live webcast:
Ask for the password from hercules (at) to follow the webcast.

09.00–09.55 Registration and coffee  


Session 1

09.55-10.00 Sampsa Hautaniemi
(HERCULES, Univ. of Helsinki)
Welcome words
10.00–11.00 Keynote: Elizabeth M. Swisher
(University of Washington)
Clinical management of ovarian cancer
11.00–11.20 Sampsa Hautaniemi
(HERCULES, Univ. of Helsinki)
Computational approaches to tackle chemoresistance in high-grade serous ovarian cancer
11.20–11.40 Ulla Puistola
(Univ. of Oulu)
Biochemical studies on carsinogenesis and chemotherapy response in ovarian cancer
11.40–12.00 Sakari Hietanen
(Univ. of Turku)

Meeting an unmet need of treatment response prediction

12.00-13.00 Lunch (free for all participants)  
12.00-13.00 Scientific Satellite Symposium sponsored by AstraZeneca (closed meeting with invitation only)*  


Session 2

13.00–14.00 Keynote: Iain McNeish
(Imperial College London)
Decoding chaos: understanding the genome in ovarian high-grade serous carcinoma
14.00–14.20 Maarit Anttila
(Univ. of Eastern Finland)
Angiogenesis in ovarian cancer
14.20–14.40 Heini Lassus
(Helsinki Univ. Hospital)
Finding putative biomarkers to high-grade serous ovarian cancer using tissue microarray
14.40–15.00 Kalle Savolainen
(Tampere Univ. Hospital)
Ovarian cancer research in Tampere Univ. Hospital Cancer Centre
15.00–15.30 Coffee break  


Session 3

15.30–15.50 Liisa Kauppi
(CHEMORESPONSE, Univ. of Helsinki)

DNA repair mechanisms in HGSOC: the molecular biology view

15.50–16.05 Wojciech Senkowski
(University of Copenhagen)
Poster presentation: Establishment of optimal in vitro conditions for culture of ovarian cancer organoids
16.05–16.20 Anniina Färkkilä
(Dana-Farber Cancer Institute & Harvard Medical School)
Poster presentation: Immunogenomic determinants of response to combination of niraparib and pembrolizumab in recurrent, platinum-resistant ovarian cancer
16.20–16.30 Kirsti Siitonen Views and experiences of an HGSOC patient

Poster session

16.30-18.00 Poster session and Sponsors' exhibition  


19.00- Dinner at restaurant Töölönranta  


* The Scientific Satellite Symposium is an official part of “Advances and  Future of High Grade Serous Ovarian Cancer Research” symposium program organized by University of Helsinki and HERCULES research project. AstraZeneca sponsors Scientific Satellite Symposium and participation is allowed by  invitation only.